E-LIB Suche - Ergebnisse für: Moore, Kathleen

1

Developing a novel image marker to predict the clinical out..:

Zhang, Ke ; Abdoli, Neman ; Gilley, Patrik...
Computers in Biology and Medicine. 172 (2024) - p. 108240 , 2024

Link: https://doi.org/10.1016/..

2

Nivolumab with or without ipilimumab in patients with recur..:

Oaknin, Ana ; Moore, Kathleen ; Meyer, Tim...
The Lancet Oncology. 25 (2024) 5 - p. 588-602 , 2024

Link: https://doi.org/10.1016/..

3

Exosomes in diagnostic and therapeutic applications of ovar..:

Bhavsar, Dhaval ; Raguraman, Rajeswari ; Kim, Dongin...
Journal of Ovarian Research. 17 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

4

The association of histopathologic features after neoadjuva..:

Mhawech-Fauceglia, Paulette ; McCarthy, Denis ; Tonooka, Akiko...
Gynecologic Oncology. 186 (2024) - p. 17-25 , 2024

Link: https://doi.org/10.1016/..

5

VELA: A first-in-human phase 1/2 study of BLU-222, a potent..:

Yap, Timothy ; Patel, Manish ; Henick, Brian...
Gynecologic Oncology. 176 (2023) - p. S173 , 2023

Link: https://doi.org/10.1016/..

6

ARTISTRY-7: A phase 3, multicenter study of nemvaleukin alf..:

Herzog, Thomas ; Hays, John ; Barlin, Joyce...
Gynecologic Oncology. 176 (2023) - p. S189 , 2023

Link: https://doi.org/10.1016/..

7

When a pandemic and epidemic collide: Lessons learned about..:

Sharp, Amanda ; Carlson, Melissa ; Vroom, Enya B....
Implementation Research and Practice. 4 (2023) - p. , 2023

Link: https://doi.org/10.1177/..

8

ENGOT-EN20/GOG-3083/XPORT-EC-042 A phase 3, randomized, pla..:

Makker, Vicky ; Vergote, Ignace ; Mirza, Mansoor...
Gynecologic Oncology. 176 (2023) - p. S156 , 2023

Link: https://doi.org/10.1016/..

9

Veterans Treatment Courts: An Exploratory Analysis of the E..:

Gerhardt, T. Freeman ; Carlson, Melissa ; Moore, Kathleen A..
Criminal Justice Policy Review. , 2023

Link: https://doi.org/10.1177/..

10

Cervical cancer geographical burden analyzer: An interactiv..:

Castellano, Tara ; Moore, Kathleen ; Ting, Jie...
Gynecologic Oncology. 169 (2023) - p. 113-117 , 2023

Link: https://doi.org/10.1016/..

11

A phase 2 study of dasatinib in recurrent clear cell carcin..:

O'Cearbhaill, Roisin E. ; Miller, Austin ; Soslow, Robert A....
Gynecologic Oncology. 176 (2023) - p. 16-24 , 2023

Link: https://doi.org/10.1016/..

12

Association of Sialyl Tn antigen with cervical cancer lymph..:

Benbrook, Doris M. ; Deng, Wei ; Gold, Michael A....
Gynecologic Oncology. 171 (2023) - p. 67-75 , 2023

Link: https://doi.org/10.1016/..

13

Evaluating the Effectiveness of 2D and 3D CT Image Features..:

Abdoli, Neman ; Zhang, Ke ; Gilley, Patrik...
Bioengineering. 10 (2023) 11 - p. 1334 , 2023

Link: https://doi.org/10.3390/..

14

Clinical analysis of pathologic complete responders in adva..:

LaFargue, Christopher J. ; Handley, Katelyn F. ; Fleming, Nicole D....
Gynecologic Oncology. 165 (2022) 1 - p. 82-89 , 2022

Link: https://doi.org/10.1016/..

15

Pharmacokinetic Interaction Between the MEK1/MEK2 Inhibitor..:

Arkenau, Hendrik‐Tobias ; Taylor, Donatienne ; Xu, Xiaoying...
Clinical Pharmacology in Drug Development. 11 (2022) 5 - p. 585-596 , 2022

Link: https://doi.org/10.1002/..